Ratiopharm

Last updated
ratiopharm
Type Private
Industry Pharmaceutical industry
Founded1974
FoundersMerckle family
Headquarters Ulm, Germany
Key people
Adolf Merckle, founder
Oliver Windholz, CEO
Products Pharmaceuticals and generic medication.
RevenueIncrease2.svg 1.8 billion (2007)
Number of employees
5,417 (2007)
Parent Teva Pharmaceutical Industries
Website Ratiopharm.com
12-08-18-tilidin-retard.jpg

Ratiopharm is a German pharmaceutical company that is Europe's leading generics brand.

Contents

Ratiopharm was owned by Adolf Merckle and makes generic pharmaceuticals. They are based in Ulm, Germany, with products being distributed[ clarification needed ] in over 35 countries worldwide.

On 18 March 2010 Teva announced that it planned to acquire Ratiopharm for US$5 billion. [1] [2] On 10 August 2010 Teva announced that it had completed its acquisition of Ratiopharm. [3]

See also

Related Research Articles

Novartis Swiss multinational pharmaceutical corporation

Novartis International AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. It is one of the largest pharmaceutical companies in the world.

An epinephrine autoinjector is a medical device for injecting a measured dose or doses of epinephrine (adrenaline) by means of autoinjector technology. It is most often used for the treatment of anaphylaxis. The first epinephrine autoinjector was brought to market in 1983.

Warner Chilcott American pharmaceutical company

Warner Chilcott was a company in the pharmaceutical industry based in Rockaway, New Jersey. It was primarily focused on women’s healthcare and dermatology. On October 1, 2013, the company was acquired by Actavis.

Adolf Merckle was a German entrepreneur and billionaire. He committed suicide at age 74 due to losses during the financial crisis of 2007–2008. He was at one point the fifth-richest person in Germany with a net worth of $9.2 billion.

Barr Pharmaceuticals Former multinational specialty and generic drug manufacturer

Barr Pharmaceuticals was a global specialty and generic drug manufacturer with operations in 30 countries.

Bausch Health Companies Inc. is a Canadian multinational specialty pharmaceutical company based in Laval, Quebec, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs, primarily for skin diseases, gastrointestinal disorders, eye health and neurology. Bausch Health owns Bausch & Lomb, a supplier of eye health products.

Baxter International Inc. is an American multinational health care company with headquarters in Deerfield, Illinois.

Mylan N.V. was a global generic and specialty pharmaceuticals company. In November 2020, Mylan merged with Upjohn, Pfizer's off-patent medicine division, to form Viatris. Previously, the company was domiciled in the Netherlands, with principal executive offices in Hatfield, Hertfordshire, UK and a "Global Center" in Canonsburg, Pennsylvania, US.

Hospira U.S. healthcare company

Hospira was an American global pharmaceutical and medical device company with headquarters in Lake Forest, Illinois. It had approximately 19,000 employees. Before its acquisition by Pfizer, Hospira was the world's largest producer of generic injectable pharmaceuticals, manufacturing generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management systems. Hospira's products are used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities. It was formerly the hospital products division of Abbott Laboratories. On September 3, 2015, Hospira was acquired by Pfizer, who subsequently sold off the medical devices portion of Hospira to ICU Medical.

Teva Pharmaceuticals Israeli pharmaceutical company

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Petah Tikva, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals. Until 2020, Teva Pharmaceuticals was the largest generic drug manufacturer, when it was surpassed by US-based Pfizer. Overall, Teva is the 18th largest pharmaceutical company in the world.

Actavis Global pharmaceutical company

Actavis Generics is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. Actavis has a commercial presence across approximately 100 countries. The company has global headquarters in Dublin, Ireland and administrative headquarters in Parsippany-Troy Hills, New Jersey, United States.

Endo International plc is an American Irish-domiciled generics and specialty branded pharmaceutical company that generated over 93% of its 2017 sales from the U.S. healthcare system. While Endo's management, operations, and customers are almost exclusively U.S.–based, in 2013 Endo executed a corporate tax inversion to Ireland to avoid U.S. corporate taxes on their U.S. drug sales, and to avail of Ireland's corporate tax system.

Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.

Cephalon, Inc. was an American biopharmaceutical company co-founded in 1987 by pharmacologist Frank Baldino, Jr., neuroscientist Michael Lewis, and organic chemist James C. Kauer—all three former scientists with the DuPont Company. Baldino served as Cephalon's chairman and chief executive officer, until his death in December 2010. The company's name comes from the adjective "cephalic" meaning "related to the head or brain", as it was established primarily to pursue treatments for neurodegenerative diseases.

Teva Canada

Teva Canada is one of Canada's largest generic pharmaceutical companies. The company was founded as Novopharm by Leslie Dan in 1965. After its acquisition by pharmaceutical giant Teva Pharmaceutical Industries in 2000, it was renamed Teva Novopharm. The Novopharm name was dropped in 2010, when it became Teva Canada.

Philipp Daniel Merckle is a German entrepreneur. From 2005 to 2008 he has headed the pharmaceutical company Ratiopharm within the family group Merckle.

Hydrocodone/ibuprofen

Hydrocodone/ibuprofen (INNs), sold under the brand name Vicoprofen, is a fixed-dose combination analgesic medication used in short-term therapy to relieve severe pain. Vicoprofen combines the analgesic and antitussive properties of hydrocodone with the analgesic, anti-inflammatory, and antipyretic properties of ibuprofen. In contrast to hydrocodone/acetaminophen combination analgesics such as Vicodin, this hydrocodone/ibuprofen avoids some of the liver toxicity which may occur from acetaminophen, but still presents significant dangers in hydrocodone overdose, namely respiratory depression. Vicoprofen is supplied in a fixed dose combination tablet which contains hydrocodone bitartrate, USP 7.5 mg with ibuprofen, USP 200 mg. Additional strengths of generic Vicoprofen are now available, in combinations of 5 mg/200 mg and 10 mg/200 mg respectively.

Intas Pharmaceuticals Indian multinational pharmaceutical company

Intas Pharmaceuticals Limited is an Indian pharmaceutical company headquartered in Ahmedabad, Gujarat.

Ludwig Kurt Merckle is a German businessman. He is CEO of Merckle Service GmbH. As of October 2021, his net worth is estimated at US$6.3 billion.

Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. The company is the maker of Botox.

References

  1. NATASHA SINGER (March 18, 2010). "Teva to Acquire Top German Generics Maker for $5 Billion". The New York Times . Retrieved March 18, 2010.
  2. Teva to Acquire Generics Firm The Wall Street Journal March 19, 2010
  3. "Teva Completes Acquisition of Ratiopharm". August 10, 2010. Archived from the original on August 18, 2010. Retrieved August 20, 2010.